Pavmed INC Form 4 insider transactions

Victoria Tou-ho Lee, Chief Medical Officer of PAVmed Inc., was granted 70,000 shares of restricted stock.

PAVM Director Lishan Aklog reported the acquisition of 350,000 restricted shares under the company's Long-Term Incentive Equity Plan.

PAVM Inc. reports that President and CFO Dennis M. McGrath was granted 180,000 shares of restricted stock under the company's Long-Term Incentive Equity Plan.

PAVmed Inc. director Michael J. Glennon acquired 13,930 shares of common stock through a restricted stock grant.

PAVmed Inc. reports that Director Timothy Baxter acquired 13,930 shares of common stock on April 2, 2026, as part of a restricted stock grant.

PAVmed Inc. reports that Director Debra White acquired 13,930 shares of common stock as restricted stock under an equity incentive plan.

PAVmed Inc. reports that Director Ronald M. Sparks acquired 13,930 shares of common stock on April 2, 2026, as part of a restricted stock grant.

PAVmed Inc. reports that Director Sundeep Agrawal acquired 13,930 shares of common stock on April 2, 2026, as part of a restricted stock grant.

Michael Adam Gordon, General Counsel of PAVmed Inc., received a grant of 110,000 restricted shares under the company's Long-Term Incentive Equity Plan.

PAVmed Inc. reports that Chief Operating Officer Shaun O'Neil was granted 110,000 shares of restricted stock on April 2, 2026, vesting in May 2029.

PAVmed Inc. Director Timothy E. Baxter received a grant of 150,000 restricted common shares, increasing his beneficial ownership to 215,000 shares.

PAVmed Inc. Director Sundeep Agrawal received a grant of 150,000 restricted common stock shares, vesting in May 2028.

PAVmed Inc. Director Ronald M. Sparks received a grant of 150,000 restricted common shares, increasing his beneficial ownership to 215,000 shares, under the company's long-term incentive plan.

PAVmed Inc. Director Debra White received a grant of 150,000 restricted common shares, vesting in May 2028, under the company's long-term incentive plan.

PAVmed Inc. Director Michael J. Glennon was granted 150,000 shares of restricted common stock, aligning his interests with shareholders.

PAVmed Inc.'s General Counsel, Michael Adam Gordon, was granted 150,000 shares of restricted common stock with a vesting date in May 2028.

PAVmed Inc.'s President and CFO, Dennis M. McGrath, was granted 150,000 shares of restricted common stock, vesting in May 2028, as part of the company's long-term incentive plan.

PAVmed Inc.'s Chairman and CEO, Lishan Aklog, was granted 150,000 restricted shares of common stock, vesting in May 2028.

PAVmed Inc.'s Chief Operating Officer, Shaun O'Neil, was granted 150,000 restricted common shares as part of the company's long-term incentive plan.

Director Sundeep Agrawal reports acquisition of 50,000 PAVmed Inc. stock options.

Director Sundeep Agrawal reports acquisition of 205,000 employee stock options in PAVmed Inc.